Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM: A 10-year follow up study

Diabetes Care

Volumn 19, Issue 5, 1996, Pages 435-440

  Yokohama, Hiroki ^a   Jensen, Jan Skov ^a   Myrup, Bjarne ^a   Mathiesen, Elisabeth R ^a   Rønn, Birgitte ^a   Deckert, Torsten ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SIALIC ACID; VON WILLEBRAND FACTOR;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; SEX DIFFERENCE; SMOKING; URINARY EXCRETION;

ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; N-ACETYLNEURAMINIC ACID; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SIALIC ACIDS; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 0029913695     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.5.435     Document Type: Article

References (35)

1. Ng S, Dain JA: The natural occurrence of sialic acids. In Biological Role of Sialic Acid. Rosenburg A, Schengrund S, Eds. New York, Plenum, 1976, p. 59-102
2. Taniuchi K, Chifu K, Hayashi N: A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. Kobe J Med Sci 27:91-102, 1981
3. Costello M, Barry A, Fiedel BA, Gewurz H: Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein. Nature 281:677-678, 1979
4. Chandrasekhar N, Warren L, Osbahr AJ, Laki K. Role of sialic acid in fibrinogen. Biochim Biophys Acta 63:337-339, 1962
5. Schnitzer JE, Pinney E. Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: role in capillary permeability Am J Physiol 32: H48-H55, 1992
6. Orekhov AN, Tertov VV, Mukhin DN: Desialylated low density lipoprotein: naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis 86:153-161, 1991
7. Rogers ME, Williams DT, Niththyananthan R, Rampling MW, Heslop KE, Johnston DG: Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes. Clin Sci 82:309-313, 1992
8. Lindberg G, Eklund G, Gullberg B, Rastam L: Serum sialic acid concentration and cardiovascular mortality. Br Med J 302:143-146, 1991
9. Lindberg G, Rastam L, Gullberg B, Eklund GA: Serum sialic acid concentration predicts both coronary heart disease and stroke mortality multivariate analysis including 54385 men and women during 20.5 years follow-up. Int J Epidemiol 21: 253-257, 1992
10. Pickup JC, Mattock MB, Crook MA, Chusney GD, Burt D, Fitzgerald AP: Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care 18:1100-1103, 1995
11. Wahl P, Deppermann D, Hasslacher C: Biochemistry of glomerular basement membrane of the normal and diabetic human. Kidney Int 21:744-749, 1982
12. Cardenas A, Schadeck C, Bernard A, Lauwerys R: Depletion of sialic acid without changes in sialidase activity in glomeruli of uninephrectomized diabetic rats. Biochem Med Metab Biol 46:416-421, 1991
13. Bernard A, Amor AO, Goemare-Vanneste J, Antoine JL, Lambert A: Urinary proteins and red blood cell membrane charges in diabetes mellitus. Clin Chim Acta 190:249-262, 1990
14. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430-1432, 1982
15. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
16. Messent JWC, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC: Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a 23 year follow-up study. Kidney Int 41:836-839, 1992
17. Yokoyama H, Jensen JS, Jensen T, Deckert T Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy J Intern Med 237:519-23, 1994
18. Crook MA, Earle K, Morocutti A, Yip J, Viberti GC, Pickup JC: Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria Diabetes Care 17:305-310, 1994
19. Jensen T: Increased plasma concentration of von Willebrand factor in insulin-dependent diabetics with incipient nephropathy. Br Med J 298:27-28, 1989
20. Jensen T, Stender S, Deckert T Abnormalities in plasma concentrations and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary excretion. Diabetologia 31:142-145, 1988
21. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamine in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:610-617, 1987
22. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC: Plasma lipid and coagulation factor concentrations in insulin-dependent diabetics with microalbuminuria Br Med J 298:487-490, 1989
23. Microalbuminuria Collaborative Study Group: Microalbuminuria in type 1 diabetic patients. Diabetes, Care 15:495-501, 1992
24. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342:883-887, 1993
25. Feldt-Rasmussen B: Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29:282-286, 1986
26. Nøgaard K, Jensen T, Feldt-Rasmussen B: Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:57-61, 1993
27. Deckert T, Kofoed-Enevoldsen A, Vidal P, Nøgaard K, Andreasen HB, Feldt-Rasmussen B: Size- and charge selectivity of glomerular filtration in type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36:244-251, 1993
28. Stehouwer CDA, Fischer HRA, van Kuijk AWR, Polak BCP, Donker AJM: Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44: 561-564, 1995
29. Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T: The relationship between blood pressure and urinary albumin excretion in the development of microalbuminuria. Diabetes 39:245-249, 1990
30. Mathiesen ER, Rønn B, Storm B, Foght H, Deckert T: Development of microalbuminuria: A 10 year prospective study (Abstract). Diabetetologia 36 (Suppl. 1):A215, 1993
31. Feldt-Rasmussen B, Dinesen B, Deckert M: Enzyme immunoassay: an improved determination of urinary albumin excretion in diabetics with incipient nephropathy. Scand J Lab Clin Invest 45:539-544, 1985
32. Simpson H, Chusney GD, Crook MA, Pickup JC: Serum sialic acid enzymatic assay based on microtiter plates: application for measuring capillary serum sialic acid concentrations. Br J Biomed Sci 50: 164-167, 1993
33. Ingerslev J: A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest 47:143-149, 1987
34. Osterby R: Glomerular structural changes m type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia 35:803-812, 1992
35. Ross R The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature 362:801-809, 1993